Brief: Yumanity Therapeutics Reports Full-Year 2021 Financial Results
March 24 (Reuters) - Yumanity Therapeutics Inc YMTX.O :
* YUMANITY THERAPEUTICS REPORTS FULL-YEAR 2021 FINANCIAL
RESULTS
AND RECENT CORPORATE DEVELOPMENTS
* YUMANITY THERAPEUTICS INC- AS OF DECEMBER 31, 2021, CASH,
CASH
EQUIVALENTS AND INVESTMENTS WERE $36.5 MILLION
* YUMANITY THERAPEUTICS- BELIEVES CASH, CASH EQUIVALENTS,
MARKETABLE SECURITIES TO NOT BE SUFFICIENT TO FUND OPERATING
EXPENSES, CAPEX REQUIREMENTS FOR 12 MONTHS
Source text for Eikon: ID:nGNX4BqqYh
Further company coverage: YMTX.O
((reuters.briefs@thomsonreuters.com;))
Recent news on Kineta
See all newsBrief: TuHURA Biosciences And Kineta Stockholders Approve Proposed Merger And All Related Proposals
Brief: Kineta Updates KVA12123 Clinical Results From Ongoing Phase 1/2 Vista101 Study At Society For Immunotherapy Of Cancer
U.S. STOCKS ON THE MOVE-Copper miners, Palo Alto Networks, Lowe's
U.S. STOCKS ON THE MOVE-Lineage, J.B. Hunt, McDonald's
Kineta rises on resuming enrollment in early-stage cancer study